EXCLUSIVE COMPOSITION FOR POLYCYSTIC OVARY SYNDROME (PCOS) TREATMENT
It is very important to notice that by not realizing these risk factors, PCOS may appear and therefore it is very important to regulate and decrease factors that influence female's reproductive health.
Number one solution is KVINOFOLIC !
Kvinofolic contains Myo-Inositol together with D-Chiro-Inositol and folic acid Quatrefolic® – the biologically active form of the naturally-occurring predominant form of folate, increase ovarian activity and menstrual frequency.
Many scientific researches confirm that the 40:1 Myo-Inositol/D-Chiro-Inositol ratio is the best for the polycystic ovary syndrome therapy aimed at restoring ovulation and normalizing main parameters in PCOS patients.
Recommended to use internally 3 capsules per day
induces glucose conversion to glycogen stored inside cells
reduces HOMA index
increases high-density lipoprotein cholesterol
decreases serum testosterone and free testosterone
promotes ovulation and menstrual frequency
decreases serum triglycerides
improves the maturity and quality of oocytes
decreases serum androgen concentrations
the biologically active form that enters directly the folate cycle
the only form of folate crossing the bloodbrain barrier
reduces the risk of neonatal neural tube defects
prevents pregnancy-related complications (congenital abnormalities, pre-term birth, anemia, peripheral neuropathy)
Irregular or missed periods
Weight changes and trouble losing weight
Loss of libido
Excessive body hair growth
High testosterone levels
PCOS can happen at any age after puberty, it is a common health condition caused by an imbalance of reproductive hormones that create problems in the ovaries and can affect fertility
Produced in EU
Impaired glucose tolerance affects 30%–40% of patients with PCOS. Insulin plays a direct role in the pathogenesis of hyperandrogenemia in PCOS, acting synergistically with LH to enhance androgen production.
Chunla He. Serum Vitamin D Levels and Polycystic Ovary syndrome: A Systematic Review and Meta-Analysis. Nutrients. 2015 Jun; 7(6): 4555–4577.
the risk of developing gestational diabetes
impaired glucose tolerance and diabetes
the risk of developing cardiovascular disease and hypertension
risk of obstructive sleep apnea
When being diagnosed with polycystic ovary syndrome, does not mean you can't get pregnant
Polycystic ovary syndrome is one of the most common conditions that could cause infertility in women, but the good news is that POLYCYSTIC OVARY SYNDROME IS TREATABLE
HELPS TO REGULATE THE MENSTRUAL CYCLE
REDUCES INSULIN RESISTANCE
Restores regular ovulation in PCOS women and decreases the effects of PCOS on reproduction, therefore helps to improve female fertility. D-chiro-inositol is involved in insulin - mediated androgen synthesis, whereas myo - inositol mediates glucose uptake and follicle stimulating hormone signaling. All compounds improve female fertility, menstrual cycles and women's reproductive health. Myo - inositol together with D-chiro-inositol and folic acid increase ovarian activity and menstrual frequency. Zinc, L - Arginine and vitamin D3 provide reproductive support for women trying to conceive.
Recommended to use internally 1 sachet per day with glass of water
corrects endocrine-metabolic disorders related to PCOS
mediates glucose uptake and follicle stimulating hormone signaling
helps to support consistent monthly cycles and hormonal balance
involved in insulin - mediated androgen synthesis
promotes blood flow to the genitalia and ovaries
provide reproductive support for women trying to conceive
increases maternal folate status that reduces the risk of development of neural tube defects in the developing fetus
improve female fertility, menstrual cycles and women's reproductive health
contributes to normal fertility and reproduction
controls several genes involved in embryo implantation
Solé Pharma® Healthcare is a dynamic Latvian pharmaceutical company that produces high quality pharmaceutical products in close collaboration with doctors, pharmacists and scientific institutes, guaranteeing excellent quality and individual approach to each customer, distributor and partner. Thanks to a professional team and modern manufacturing site, Solé Pharma® Healthcare's portfolio includes over 50 different formulas, including worldwide recognizable brands. Solé Pharma® products contain amino acids, herbal extracts, vitamins, micro and macro elements that have proven to be effective in clinical trials and daily practice.
Thanks to the scientific department, Solé Pharma® Healthcare develops new formulas every year, taking into account the individual needs of each country. The company has gained international reputation for continuous development and effective cooperation, which has been established in 22 countries in Europe, Middle east and Asia. The company focuses on the development and production of high-quality original products based on the latest technology in science. Solé Pharma®'s mission is to improve the quality of life by offering high quality original pharmaceutical products.
Quality and safety ensured.
Kvinofolic is developed by experts and leaders in gynecology, using scientific evidence. Kvinofolic is manufactured in Latvia, European Union to the high standards of international pharmaceutical Good Manufacturing Practice.
Amino acids in Kvinofolic are subjected to high quality standards including use of the latest and the most relevant chemical analytic methods.